Press release
direct/ Antisoma plc (UK) - Antisoma to present at the BIO CEO conference
10 February 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Director of Communications, Dr Daniel Elger, will participate in a panel session entitled "Revisiting Cytotoxics with New Molecules" at the BIO CEO and Investor Conference on Tuesday 14 February at 9.00am EST at the Waldorf Astoria Hotel in New York.Antisoma´s presentation will consider the potential to improve outcomes in patients receiving cytotoxic chemotherapy by co-treatment with the Company´s vascular disrupting agent, AS1404.
A webcast of the session will be available at http://ceo.bio.org/opencms/ceo/2006/index.jsp from 12 hours after the presentation.
Enquiries:
Margherita Lupi
Communications Manager
+44 (0)20 8799 8200
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Antisoma has a broad strategic alliance with Roche to develop and commercialise products from its pipeline. Please visit www.antisoma.com for further information.
The announcement distributed by directnews.
The issuer is solely responsible for the content of this announcement.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release direct/ Antisoma plc (UK) - Antisoma to present at the BIO CEO conference here
News-ID: 4660 • Views: …
More Releases from Antisoma plc
direct/ Antisoma plc (UK) - Antisoma to present at Piper Jaffray Health Care Con …
20 June 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at Piper Jaffray´s first London Health Care Conference on Friday 23 June at 12.00 BST.
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised…
direct/ Antisoma plc (UK) - Antisoma to present at the Rodman and Renshaw confer …
10 May 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at the Rodman and Renshaw 3rd Annual Global Healthcare Conference on Tuesday 16 May at 13:00 CET in Monte Carlo.
A webcast of the presentation will be available on Antisoma´s website www.antisoma.com . It is recommended that viewers log on 15 minutes early in…
More Releases for February
Springwell Clinic's Emsella Chair February Giveaway
SPRINGWELL Clinic, one of Marlow's leading health and beauty clinics, are giving away two free courses of Emsella Chair treatments in February, worth £1500.
This month, Springwell Clinic are giving away two free courses of Esmella Chair treatments, a groundbreaking technology that aims to dramatically improve a patient's pelvic floor muscles, to address issues such as:
Incontinence
Intimate discomfort
Sexual dysfunction in both men and women
The Emsella Chair is a non-invasive…
Women Entrepreneurs Boot Camp – February 12, 2011
NO THEORY, PHILOSOPHY OR FLUFF!
PHOENIX –November 29th, 2010 – Where can a women business owner find powerful, world-class insights and cutting edge strategies? At the seventh annual Women Entrepreneurs’ Small Business Boot Camp, where else?
“The full day conference includes two keynote presentations, nine workshops and 50 exhibitors, all providing practical tips and ammunition to fire-up your business,” describes Susan Ratliff, the founder of the state-wide event and…
BBB Consumer Alerts for February 2009
BBB Warns of Garner-based Web Retailer
Online Weight-Loss Company Highlighted in February Consumer Alerts
RALEIGH, N.C. (February 19, 2009) - The Better Business Bureau (BBB) of Eastern North Carolina (www.bbb.org) warns consumers to be cautious when dealing with companies offering free trials, especially when a credit or debit card is used to cover shipping and handling costs. Complaints are being filed regarding the deceptive practices of an online company with a post…
Landrush of asia-domains begins February 20
The Sunrise Period of asia-domains has closed at 2008 January 31. Individual companies and the general public will soon be eligible to register for available asia-domains when the Landrush phase kicks off on February 20, 2008. Landrush concludes on March 12, with Go Live scheduled for March 26, 2008.
During the Landrush phase anyone around the world can apply for any available asia-domains, representing a golden opportunity for individuals looking to…
Analytiqa: Logistics Bulletin: Friday 23rd February
This week\'s Logistics Bulletin takes global expansion as its theme. In the last week, Schneider National has received the go-ahead for operations in China, Thiel Logistik is expanding its presence in South America, DPWN has announced multi million dollar investments in the Middle East and major logistics hubs are to be established in Russia.
Elsewhere, computer manufacturer Dell has established a new Global operations organisation, whilst retailer Decathlon is expanding…
Analytiqa: Logistics Bulletin: Friday 16th February
This week's Logistics Bulletin reports on yet more M&A developments. In the US, EGL has revealed that it has authorised its financial advisor to solicit interest from third parties for the sale of the Company. Elsewhere, Palletways Europe, Europe's largest and fastest growing pallet freight network, has acquired the Italian operation it licensed out in 2002 and ProLogis has acquired the industrial development business of Parkridge, a leading European developer…
